array:34 [ "id" => array:1 [ 0 => array:1 [ "value" => "3638" ] ] "isin" => array:1 [ 0 => array:1 [ "value" => "DE000LS9M1C4" ] ] "wkn" => array:1 [ 0 => array:1 [ "value" => "LS9M1C" ] ] "name" => array:1 [ 0 => array:1 [ "value" => "SMCAPBIO" ] ] "short_description" => array:1 [ 0 => array:1 [ "value" => "Hedged Biotech Gems" ] ] "long_description" => array:1 [ 0 => array:1 [ "value" => """ Der Fokus soll hier grundsätzlich auf amerikanischen Werten der Biotechnologie Branche liegen. In Ausnahmefällen können es auch Werte außerhalb des amerikanischen Raumes sein. In der Regel sollten die Unternehmen bereits in der Klinik sein und wenn möglich late stage Produktkandidaten in ihrer Pipeline haben. Idealerweise sollten die Unternehmen meiner Ansicht nach in die Marktkapitalisierung der Gruppen Small / Mid Cap fallen. Zu einem kleinen Prozentsatz können auch Large Caps berücksichtigt werden. Mein Ziel ist es die Performance der beiden großen Biotech - ETFs zu übertreffen. Dieses Ziel möchte ich im wesentlichen durch die Berücksichtigung der "Catalysts" wie beispielsweise PDUFA Datum, Veröffentlichung von klinischen Daten oder Regulatory Feedback von der FDA erreichen. Bei fallenden Märkten soll generell das wikifolio durch ETFs abgesichert werden.\r\n \r\n Betreffend des Anlageuniversums soll das wikifolio Aktien und ETFs beinhalten.\r\n \r\n Der Anlagehorizont soll normalerweise kurz- bis mittelfristig sein. """ ] ] "status" => array:1 [ 0 => array:1 [ "value" => "Investable" ] ] "trader_name" => array:1 [ 0 => array:1 [ "value" => "Akzidens" ] ] "symbol" => array:1 [ 0 => array:1 [ "value" => "WFSMCAPBIO" ] ] "creation_date" => array:1 [ 0 => array:1 [ "value" => "1516354562" ] ] "issuing_date" => array:1 [ 0 => array:1 [ "value" => "1525404783" ] ] "daily_free_relative" => array:1 [ 0 => array:1 [ "value" => "0.95" ] ] "performance_free_relative" => array:1 [ 0 => array:1 [ "value" => "12" ] ] "cash" => array:1 [ 0 => array:1 [ "value" => "5279.35" ] ] "url" => array:1 [ 0 => array:1 [ "value" => "https://www.wikifolio.com/de/ch/w/wfsmcapbio" ] ] "href" => array:1 [ 0 => array:1 [ "value" => "https://api.wikifolio.com/api/v1/wikifolios/de000ls9m1c4" ] ] "wikifolio_tags" => array:1 [ 0 => array:1 [ "value" => "a:10:{i:0;a:3:{s:4:"Name";s:3:"etf";s:16:"ShortDescription";s:4:"ETFs";s:8:"TagGroup";s:15:"Anlageuniversum";}i:1;a:3:{s:4:"Name";s:6:"akteur";s:16:"ShortDescription";s:13:"Aktien Europa";s:8:"TagGroup";s:15:"Anlageuniversum";}i:2;a:3:{s:4:"Name";s:11:"fundamental";s:16:"ShortDescription";s:20:"Fundamentale Analyse";s:8:"TagGroup";s:20:"Entscheidungsfindung";}i:3;a:3:{s:4:"Name";s:5:"aktde";s:16:"ShortDescription";s:18:"Aktien Deutschland";s:8:"TagGroup";s:15:"Anlageuniversum";}i:4;a:3:{s:4:"Name";s:10:"schwer-usa";s:16:"ShortDescription";s:15:"Schwerpunkt USA";s:8:"TagGroup";s:35:"ExtendedSearchInvestmentRegionGroup";}i:5;a:3:{s:4:"Name";s:8:"sonstige";s:16:"ShortDescription";s:16:"Sonstige Analyse";s:8:"TagGroup";s:20:"Entscheidungsfindung";}i:6;a:3:{s:4:"Name";s:6:"aktint";s:16:"ShortDescription";s:20:"Aktien International";s:8:"TagGroup";s:15:"Anlageuniversum";}i:7;a:3:{s:4:"Name";s:6:"akthot";s:16:"ShortDescription";s:17:"Aktien Hot Stocks";s:8:"TagGroup";s:15:"Anlageuniversum";}i:8;a:3:{s:4:"Name";s:6:"aktusa";s:16:"ShortDescription";s:10:"Aktien USA";s:8:"TagGroup";s:15:"Anlageuniversum";}i:9;a:3:{s:4:"Name";s:8:"techanal";s:16:"ShortDescription";s:18:"Technische Analyse";s:8:"TagGroup";s:20:"Entscheidungsfindung";}}" ] ] "rankings" => array:1 [ 0 => array:1 [ "value" => "a:8:{i:0;a:4:{s:4:"Name";s:3:"aum";s:16:"ShortDescription";s:19:"Summe Investitionen";s:5:"Value";d:662.800616;s:5:"Index";i:3896;}i:1;a:4:{s:4:"Name";s:8:"topwikis";s:16:"ShortDescription";s:23:"Top-wikifolio-Rangliste";s:5:"Value";d:0;s:5:"Index";i:24536;}i:2;a:4:{s:4:"Name";s:6:"perf1m";s:16:"ShortDescription";s:19:"Performance 1 Monat";s:5:"Value";d:0;s:5:"Index";i:25993;}i:3;a:4:{s:4:"Name";s:7:"perf12m";s:16:"ShortDescription";s:18:"Performance 1 Jahr";s:5:"Value";d:46.37481877;s:5:"Index";i:3754;}i:4;a:4:{s:4:"Name";s:8:"perfever";s:16:"ShortDescription";s:23:"Performance seit Beginn";s:5:"Value";d:10.466769343329;s:5:"Index";i:40295;}i:5;a:4:{s:4:"Name";s:6:"perf3m";s:16:"ShortDescription";s:20:"Performance 3 Monate";s:5:"Value";d:8.638363402;s:5:"Index";i:14899;}i:6;a:4:{s:4:"Name";s:6:"perf6m";s:16:"ShortDescription";s:20:"Performance 6 Monate";s:5:"Value";d:7.125968401;s:5:"Index";i:16217;}i:7;a:4:{s:4:"Name";s:7:"maxdraw";s:16:"ShortDescription";s:26:"maximaler Verlust (bisher)";s:5:"Value";d:-72.6737735436;s:5:"Index";i:89930;}}" ] ] "wikifolio_items" => array:1 [ 0 => array:1 [ "value" => "a:30:{i:0;a:8:{s:4:"ISIN";s:12:"NL0010696654";s:3:"WKN";s:6:"A1XDTV";s:16:"ShortDescription";s:25:"UNIQURE N.V. EO -,05";s:13:"AbsoluteValue";d:1876.5;s:13:"RelativeValue";d:0.35544156610638306;s:12:"AbsoluteGain";d:-949.427334735615;s:12:"RelativeGain";d:-0.3359701868712206;s:8:"Quantity";d:45;}i:1;a:8:{s:4:"ISIN";s:12:"US00289Y2063";s:3:"WKN";s:6:"A3DMHM";s:16:"ShortDescription";s:25:"ABEONA THERAPEUT. DL-,01";s:13:"AbsoluteValue";d:97.78;s:13:"RelativeValue";d:0.018521223732417873;s:12:"AbsoluteGain";d:-2609.02;s:12:"RelativeGain";d:-0.9638761637357766;s:8:"Quantity";d:20;}i:2;a:8:{s:4:"ISIN";s:12:"SE0009414576";s:3:"WKN";s:6:"A2DLU2";s:16:"ShortDescription";s:20:"ONCOPEPTIDES AB O.N.";s:13:"AbsoluteValue";d:14.1;s:13:"RelativeValue";d:0.002670783949960033;s:12:"AbsoluteGain";d:-1262.9;s:12:"RelativeGain";d:-0.9889584964761159;s:8:"Quantity";d:100;}i:3;a:8:{s:4:"ISIN";s:12:"US04280A1007";s:3:"WKN";s:6:"A2AGYB";s:16:"ShortDescription";s:25:"ARROWHEAD PHARMAC. DL-,01";s:13:"AbsoluteValue";d:1406;s:13:"RelativeValue";d:0.26632072579034083;s:12:"AbsoluteGain";d:378.92653061224;s:12:"RelativeGain";d:0.36893809635460517;s:8:"Quantity";d:20;}i:4;a:8:{s:4:"ISIN";s:12:"US09075P2048";s:3:"WKN";s:6:"A40YSR";s:16:"ShortDescription";s:22:"BIOXCEL THERAP.INC.NEW";s:13:"AbsoluteValue";d:1.6328125;s:13:"RelativeValue";d:0.0003092829374676678;s:12:"AbsoluteGain";d:-1100.700520833325;s:12:"RelativeGain";d:-0.998518767009374;s:8:"Quantity";d:1.5625;}i:5;a:8:{s:4:"ISIN";s:12:"US05464T1043";s:3:"WKN";s:6:"A2AA7B";s:16:"ShortDescription";s:25:"AXSOME THERAPEUT. DL-0001";s:13:"AbsoluteValue";d:32865;s:13:"RelativeValue";d:6.225199611023863;s:12:"AbsoluteGain";d:24710.90802799185;s:12:"RelativeGain";d:3.0304916982566446;s:8:"Quantity";d:150;}i:6;a:8:{s:4:"ISIN";s:12:"US05280R1005";s:3:"WKN";s:6:"A2JNZJ";s:16:"ShortDescription";s:24:"AUTOLUS THERAP. SP.ADR/1";s:13:"AbsoluteValue";d:399;s:13:"RelativeValue";d:0.07557750326482646;s:12:"AbsoluteGain";d:-2168.4999999999;s:12:"RelativeGain";d:-0.8445959104186892;s:8:"Quantity";d:300;}i:7;a:8:{s:4:"ISIN";s:12:"US14147L1089";s:3:"WKN";s:6:"A2P4GU";s:16:"ShortDescription";s:25:"CARDIFF ONCOLOG. DL-,0001";s:13:"AbsoluteValue";d:204.2;s:13:"RelativeValue";d:0.038679012949066574;s:12:"AbsoluteGain";d:-2480.0857142856;s:12:"RelativeGain";d:-0.9239276210750367;s:8:"Quantity";d:200;}i:8;a:8:{s:4:"ISIN";s:12:"US15117K1034";s:3:"WKN";s:6:"A14QZE";s:16:"ShortDescription";s:25:"CELLECTIS SP.ADR 1 EO-,05";s:13:"AbsoluteValue";d:536;s:13:"RelativeValue";d:0.10152767355876437;s:12:"AbsoluteGain";d:-1164;s:12:"RelativeGain";d:-0.6847058823529412;s:8:"Quantity";d:200;}i:9;a:8:{s:4:"ISIN";s:12:"US20451W1018";s:3:"WKN";s:6:"A2QCDR";s:16:"ShortDescription";s:20:"COMPASS PATHW SP.ADR";s:13:"AbsoluteValue";d:1545;s:13:"RelativeValue";d:0.29264973068711;s:12:"AbsoluteGain";d:-2265;s:12:"RelativeGain";d:-0.594488188976378;s:8:"Quantity";d:150;}i:10;a:8:{s:4:"ISIN";s:12:"US28106W1036";s:3:"WKN";s:6:"A2AC4K";s:16:"ShortDescription";s:25:"EDITAS MEDICINE DL-,0001";s:13:"AbsoluteValue";d:110;s:13:"RelativeValue";d:0.020835903155716567;s:12:"AbsoluteGain";d:-1957.4205217392;s:12:"RelativeGain";d:-0.9467936015709744;s:8:"Quantity";d:50;}i:11;a:8:{s:4:"ISIN";s:12:"US31572Q8814";s:3:"WKN";s:6:"A419WK";s:16:"ShortDescription";s:25:"KYNTRA BIO INC. NEW O.N.";s:13:"AbsoluteValue";d:30.25;s:13:"RelativeValue";d:0.005729873367822056;s:12:"AbsoluteGain";d:-5456.84416666675;s:12:"RelativeGain";d:-0.9944870638117049;s:8:"Quantity";d:5;}i:12;a:8:{s:4:"ISIN";s:12:"US70465T1079";s:3:"WKN";s:6:"A2PF3F";s:16:"ShortDescription";s:23:"PDS BIOTECHNOLOGY CORP.";s:13:"AbsoluteValue";d:117.9;s:13:"RelativeValue";d:0.022332299836899848;s:12:"AbsoluteGain";d:-997.54999999995;s:12:"RelativeGain";d:-0.8943027477699536;s:8:"Quantity";d:150;}i:13;a:8:{s:4:"ISIN";s:12:"US6402683063";s:3:"WKN";s:6:"A419UB";s:16:"ShortDescription";s:25:"NEKTAR THERAP. NEW O.N.";s:13:"AbsoluteValue";d:723.609;s:13:"RelativeValue";d:0.13706406406004462;s:12:"AbsoluteGain";d:-4325.001000000096;s:12:"RelativeGain";d:-0.8566716383321377;s:8:"Quantity";d:13.653;}i:14;a:8:{s:4:"ISIN";s:12:"US67576A1007";s:3:"WKN";s:6:"A1180P";s:16:"ShortDescription";s:25:"OCULAR THERAPEUT.DL-,0001";s:13:"AbsoluteValue";d:2268.75;s:13:"RelativeValue";d:0.4297405025866542;s:12:"AbsoluteGain";d:-1430.826923076925;s:12:"RelativeGain";d:-0.3867542026635065;s:8:"Quantity";d:275;}i:15;a:8:{s:4:"ISIN";s:12:"US6700024010";s:3:"WKN";s:6:"A2PKMZ";s:16:"ShortDescription";s:25:"NOVAVAX INC. DL-,01";s:13:"AbsoluteValue";d:123.75;s:13:"RelativeValue";d:0.02344039105018114;s:12:"AbsoluteGain";d:-2430.049999999995;s:12:"RelativeGain";d:-0.9515427989662463;s:8:"Quantity";d:15;}i:16;a:8:{s:4:"ISIN";s:12:"US5560991094";s:3:"WKN";s:6:"A1W6ND";s:16:"ShortDescription";s:25:"MACROGENICS INC. DL-,01";s:13:"AbsoluteValue";d:516;s:13:"RelativeValue";d:0.09773932753045225;s:12:"AbsoluteGain";d:-2566.99999999995;s:12:"RelativeGain";d:-0.8326305546545545;s:8:"Quantity";d:150;}i:17;a:8:{s:4:"ISIN";s:12:"US5588681057";s:3:"WKN";s:6:"A2APCZ";s:16:"ShortDescription";s:25:"MADRIGAL PHARMAC. DL-,01";s:13:"AbsoluteValue";d:17332;s:13:"RelativeValue";d:3.2829806681352687;s:12:"AbsoluteGain";d:12743.24571428572;s:12:"RelativeGain";d:2.7770599428167295;s:8:"Quantity";d:40;}i:18;a:8:{s:4:"ISIN";s:12:"US50127T1097";s:3:"WKN";s:6:"A143UH";s:16:"ShortDescription";s:23:"KURA ONCOLOGY DL-,0001";s:13:"AbsoluteValue";d:416;s:13:"RelativeValue";d:0.07879759738889175;s:12:"AbsoluteGain";d:-1134;s:12:"RelativeGain";d:-0.7316129032258064;s:8:"Quantity";d:50;}i:19;a:8:{s:4:"ISIN";s:12:"US4831193010";s:3:"WKN";s:6:"A4243T";s:16:"ShortDescription";s:18:"KALA BIO INC. O.N.";s:13:"AbsoluteValue";N;s:13:"RelativeValue";N;s:12:"AbsoluteGain";N;s:12:"RelativeGain";N;s:8:"Quantity";d:0.36;}i:20;a:8:{s:4:"ISIN";s:12:"US48576U2050";s:3:"WKN";s:6:"A40YLC";s:16:"ShortDescription";s:25:"KARYOPHARM TH.NEW.DL-0001";s:13:"AbsoluteValue";d:434.232;s:13:"RelativeValue";d:0.08225105362830105;s:12:"AbsoluteGain";d:-11559.267999999987;s:12:"RelativeGain";d:-0.963794388627173;s:8:"Quantity";d:53.28;}i:21;a:8:{s:4:"ISIN";s:12:"US52187K2006";s:3:"WKN";s:6:"A3EMJP";s:16:"ShortDescription";s:23:"CYPHERPUNK TECHNOLOGIES";s:13:"AbsoluteValue";d:49.35;s:13:"RelativeValue";d:0.009347743824860115;s:12:"AbsoluteGain";d:-1425.65000000025;s:12:"RelativeGain";d:-0.9665423728813616;s:8:"Quantity";d:75;}i:22;a:8:{s:4:"ISIN";s:12:"US88322Q1085";s:3:"WKN";s:6:"A1JXW7";s:16:"ShortDescription";s:25:"TG THERAPEUTICS DL -,001";s:13:"AbsoluteValue";d:13380;s:13:"RelativeValue";d:2.534403492940797;s:12:"AbsoluteGain";d:4107.6156652731;s:12:"RelativeGain";d:0.4429945434734918;s:8:"Quantity";d:300;}i:23;a:8:{s:4:"ISIN";s:12:"US92686J1060";s:3:"WKN";s:6:"A12GD6";s:16:"ShortDescription";s:25:"VIKING THERAPEUT.DL -,005";s:13:"AbsoluteValue";d:30371.25;s:13:"RelativeValue";d:5.752840215618698;s:12:"AbsoluteGain";d:21840.717831648613;s:12:"RelativeGain";d:2.5602995687277916;s:8:"Quantity";d:1157;}i:24;a:8:{s:4:"ISIN";s:12:"US92790C1045";s:3:"WKN";s:6:"A2QMUH";s:16:"ShortDescription";s:21:"VIRIDIAN THERAPEUTICS";s:13:"AbsoluteValue";d:662.6004;s:13:"RelativeValue";d:0.12550797968490054;s:12:"AbsoluteGain";N;s:12:"RelativeGain";N;s:8:"Quantity";d:46.662;}i:25;a:8:{s:4:"ISIN";s:12:"US92915B1061";s:3:"WKN";s:6:"A143XJ";s:16:"ShortDescription";s:25:"VOYAGER THERAP. DL -,001";s:13:"AbsoluteValue";d:234.3;s:13:"RelativeValue";d:0.044380473721676285;s:12:"AbsoluteGain";d:-748.2;s:12:"RelativeGain";d:-0.7615267175572519;s:8:"Quantity";d:75;}i:26;a:8:{s:4:"ISIN";s:12:"US8693672011";s:3:"WKN";s:6:"A41VMF";s:16:"ShortDescription";s:25:"SUTRO BIOPHARMA NEW O.N.";s:13:"AbsoluteValue";d:184.5;s:13:"RelativeValue";d:0.03494749211117915;s:12:"AbsoluteGain";d:-1233.999999999975;s:12:"RelativeGain";d:-0.8699330278463142;s:8:"Quantity";d:7.5;}i:27;a:8:{s:4:"ISIN";s:12:"US76029N1063";s:3:"WKN";s:6:"A2JQN1";s:16:"ShortDescription";s:25:"REPLIMUNE GR. INC DL-,001";s:13:"AbsoluteValue";d:173.12;s:13:"RelativeValue";d:0.032791923221069566;s:12:"AbsoluteGain";d:-630.88;s:12:"RelativeGain";d:-0.7846766169154229;s:8:"Quantity";d:20;}i:28;a:8:{s:4:"ISIN";s:12:"CA03835T4081";s:3:"WKN";s:6:"A40YEP";s:16:"ShortDescription";s:22:"APTOSE BIOSCI.JAN 2025";s:13:"AbsoluteValue";d:3.74250375;s:13:"RelativeValue";d:0.0007088949608627826;s:12:"AbsoluteGain";N;s:12:"RelativeGain";N;s:8:"Quantity";d:2.772225;}i:29;a:8:{s:4:"ISIN";s:12:"CA98420N1050";s:3:"WKN";s:6:"A12ETN";s:16:"ShortDescription";s:21:"XENON PHARMACEUTICALS";s:13:"AbsoluteValue";d:6930;s:13:"RelativeValue";d:1.3126618988101437;s:12:"AbsoluteGain";d:4391.86285714275;s:12:"RelativeGain";d:1.7303489173160715;s:8:"Quantity";d:150;}}" ] ] "licence_switzerland" => array:1 [ 0 => array:1 [ "value" => "0" ] ] "perf1m" => array:1 [ 0 => array:1 [ "value" => "0" ] ] "perf12m" => array:1 [ 0 => array:1 [ "value" => "46.3748" ] ] "perfever" => array:1 [ 0 => array:1 [ "value" => "10.4668" ] ] "aum" => array:1 [ 0 => array:1 [ "value" => "662.801" ] ] "topwikis" => array:1 [ 0 => array:1 [ "value" => "24536" ] ] "created" => array:1 [ 0 => array:1 [ "value" => "1649766873" ] ] "changed" => array:1 [ 0 => array:1 [ "value" => "1781731508" ] ] "solid_valor" => array:1 [ 0 => array:1 [ "value" => "41700641" ] ] "solid_bc" => array:1 [ 0 => array:1 [ "value" => "EUW" ] ] "solid_bc_id" => array:1 [ 0 => array:1 [ "value" => "521" ] ] "solid_cc" => array:1 [ 0 => array:1 [ "value" => "EUR" ] ] "solid_cc_id" => array:1 [ 0 => array:1 [ "value" => "814" ] ] "fullquote_link" => array:1 [ 0 => array:1 [ "value" => "wikifolio/wfsmcapbio-ls-open-41700641/euw/eur" ] ] "solid_changed" => array:1 [ 0 => array:1 [ "value" => "1661288779" ] ] ]